Open AccessThe Global Threat of Counterfeit Drugs: Why Industry and Governments Must Communicate the Dangers
Author(s) -
Robert Cockburn,
Paul N. Newton,
E. Kyeremateng Agyarko,
Dora Akunyili,
Nicholas J. White
Publication year - 2005
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.0020100
Subject(s) - counterfeit drugs , counterfeit , business , drug industry , internet privacy , environmental health , medicine , computer security , political science , microbiology and biotechnology , computer science , law , biology
The production of substandard and fake drugs is a vast and underreported problem, particularly affecting poorer countries. Cockburn and colleagues argue that the pharmaceutical industry and governments must both take action
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom